Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse CancersAaron M. Goodman, Razelle Kurzrock, Philip J. Stephens et al.|Molecular Cancer Therapeutics|2017Cited by 2.4k
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trialsAakash Desai, Vivek Subbiah, Justin F. Gainor et al.|Nature Reviews Clinical Oncology|2021Cited by 140
ALK fusions in the pan-cancer setting: another tumor-agnostic target?Aditya Shreenivas, Razelle Kurzrock, Shumei Kato et al.|npj Precision Oncology|2023Cited by 89